Another Step for Patients: Cold Cap Technology Introduced at Oncology Institute to Reduce Hair Loss

Hillel Yaffe Medical Center is expanding its range of services for chemotherapy patients with the introduction of scalp cooling treatment ("cold cap"), which helps reduce hair loss. The new device, which the hospital's Oncology Institute put into service in recent weeks, marks another milestone in the range of advanced services designed to make things easier for patients and improve their quality of life during their complex cancer journey. 

The FDA-approved cold cap significantly reduces hair loss due to chemotherapy through controlled cooling of the scalp, which minimizes damage to hair follicles from the medications. Treatment is administered before, during and after the infusion and has proven particularly effective among patients with various cancer types, especially breast cancer treated with taxane-type drugs. Beyond its physical benefits, the cap plays an important role in reducing the emotional distress associated with hair loss - one of the most difficult and challenging side effects of chemotherapy, with a significant impact on self-image and coping. 

Najem Biadsi, breast care nurse coordinator at the Oncology Institute at Hillel Yaffe, instructs a patient on use of the cold cap

Purchase of the system was made possible thanks to the generous support of the Israel Cancer Association, Bank Hapoalim and other donors, who recognized the importance of this service as a direct contribution to the quality of life of oncology patients. 

Dr. Valeriya Semenisty, Director of the Oncology Institute at Hillel Yaffe Medical Center, said, “Hair loss is far more than a side effect. For many patients, it's a visible expression of the disease and a major blow to emotional resilience, which is vital to recovery. Introducing scalp cooling is an important step that complements the advanced treatment technologies, diagnostics and support services we offer at the Oncology Institute. Our goal is to provide outstanding medical care alongside a compassionate and respectful treatment experience. We are grateful to our generous donors who made the cold cap purchase possible, first and foremost the Israel Cancer Association, with whom we have worked in partnership for years." 

In December 2024, Hillel Yaffe inaugurated a new Hematology-Oncology Center, one of the most advanced of its kind in Israel, spanning approximately 1,800 square meters. The introduction of scalp cooling technology represents another step in building a comprehensive, advanced and holistic support system for patients in the region.